Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Catheter Precision, Inc. Common Stock (NY: VTAK )

0.3560 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EST, Feb 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Catheter Precision, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
Catheter Precision (NYSE American: VTAK) Announces New LockeT Purchase Order and Expands Sales Team Amid Surge in Trading Volume
Via AB Newswire
Catheter Precision, Inc. Announces Receipt of LockeT Purchase Order for Eisenhower Medical Center, a Third California Hospital
Via ACCESSWIRE
GameStop Raises $2.14 Billion, Meme Stocks Buzz Fuels Gains Watch: GME, PRSO, DYAI, VTAK, AMC
Via AB Newswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Exploring Top NASDAQ Stocks Under $1 Gaining Traction: KITT, AEMD, VTAK, TELL, KWE
Via AB Newswire
Topics Energy
Exposures Fossil Fuels
Catheter Precision, Inc. (VTAK) Announces Receipt of New Purchase Order and Product Evaluation at New Hospital
Via ACCESSWIRE
Spotlighting Noteworthy Companies, Insights and Recent News Cycles: FFIE, VTAK, ASTI, BNED, PEGY
Via AB Newswire
“Cutting-Edge Medical Innovations Propel Catheter Precision Inc. (NYSE American: VTAK) Forward”
Via AB Newswire
Top Stocks to Watch: FFIE, PLUG, SPWR, More Inside!
Via AB Newswire
Spotlight: Healthcare and Tech VTAK, ORGO, CDIO, LAZR, VLCN
Via AB Newswire
Catheter Precision, Inc. (NYSE: VTAK) Announces Initial Orders from Ronald Reagan UCLA Medical Center and Rady Children’s Hospital in San Diego for LockeT
Via ACCESSWIRE
Market Movers on The Street: LAZR, INBS, REBN, PSRO
Via AB Newswire
Catheter Precision Inc. (NYSE American: VTAK) Announces Purchase Order From University of California San Diego (UCSD) Health System
Via AB Newswire
Investor Spotlight: Companies Poised for Growth Amid Recent Developments: VTAK, ESPR, FGEN, GSUN, INBS
Via AB Newswire
VTAK Stock Earnings: Catheter Precision, Inc. Common Stock Beats EPS, Misses Revenue for Q1 2024
VTAK stock results show that Catheter Precision, Inc. Common Stock beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Catheter Precision, Inc. (NYSE American: VTAK) Reports Q1 2024 Highlights and Operational Performance Report
Via ACCESSWIRE
Catheter Precision, Inc. (NYSE-American: VTAK) Announces New Chief Commercial Officer
Via ACCESSWIRE
Discovering Undervalued Stocks in Today’s Market: OCGN, INBS, KAVL, DYAI, VTAK
Via AB Newswire
Catheter Precision Inc. (NYSE American: VTAK) Stock Surges Following LockeT Purchase Order from HCA Healthcare
Via AB Newswire
Stocks Creating Buzz Look Now: VTAK, AMST, HOOK, MULN, KAVL
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Catheter Precision, Inc. (VTAK) Announces Receipt of First Purchase Order for LockeT from HCA Healthcare Facility
Via ACCESSWIRE
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK
Via AB Newswire
Medical Device Innovator Catheter Precision Inc. (NYSE American: VTAK) Gains Momentum with LockeT and VIVO™ Products – Full Analysis Inside!
Via AB Newswire
Key Stocks to Watch: Recent News, Developments and Market Potential KAVL, INBS, GEVI, VTAK, RLYB
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
Ladenburg Thalmann, Esteemed Wall Street Long-Standing Stalwart Since 1876, Advocates ‘Buy’ for Intelligent Bio, Precision Bio, and More: VTAK, INBS, LASE, MYMD, RVSN
Via AB Newswire
Momentum Stocks Alert: DYAI, KAVL, VTAK, NKLA, ATAI Demonstrate Financial Growth and Strategic Advancements
Via AB Newswire
Catheter Precision (NYSE American: VTAK) Shows Fiscal Strength, Solid Growth and Strategic Moves; Bullish Momentum Seen in Stock Price
Via AB Newswire
Catheter Precision, Inc. (NYSE-American:VTAK) Expands Sales Team; Expects Corresponding Rise in Revenue Over the Near Term; Anticipates Breakeven by End of Year
Via ACCESSWIRE
Catheter Precision, Inc. (NYSE American:VTAK) Releases Operational Performance Report, Q4 and Annual 2023 Financials for Year Ending December 31, 2023
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.